Products 61263-32-9

CAS 61263-32-9 appears in our catalog under these names: 9-deoxy-9-methylene Prostaglandin E2, 9–deoxy–9–methylene Prostaglandin E2. Offered by: TargetMol, GLPBio, MedChemExpress. Available pack sizes: 1mg, 5mg, 10mg, 10 mg, 1 mg, 5 mg.

9-deoxy-9-methylene Prostaglandin E2
TargetMol, MedChemExpress
  • size: 1mg, 5mg, 10mg, 10 mg
  • Variants: 6
from 1348.75
View product
9–deoxy–9–methylene Prostaglandin E2
GLPBio
  • size: 1mg, 10mg, 5mg
  • Variants: 3
from 887.23
View product
Structural formula: {0} (CAS {1})

9-Deoxy-9-methylene-PGE2 is a long-chain fatty acid.

Source: ChEBI

Identity
Molecular formulaC21H34O4
Molecular weight350.5 g/mol
IUPAC name(Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-methylidenecyclopentyl]hept-5-enoic acid
InChIKeyVKEJXDXJUFQESA-DLMPNJEASA-N
SMILESCCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=C)[C@@H]1C/C=C\CCCC(=O)O)O)O

Computed by PubChem (NCBI)

Synonyms: 9-deoxy-9-methylene Prostaglandin E2, 9-deoxy-9-methylene-Prostaglandin E2, 9-deoxy-9-methylene-PGE2, 9-methylene-11R,15S-dihydroxy-5Z,13E-prostadienoic acid, 9-Deoxy-9-methylene-PGF2, 9-deoxy-9-methylene PGE2, orb1693494
Isomers (same molecular formula)
1-[(3R,5R,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
1-[(3R,5S,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17R)-3,17-dihydroxy-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one C21H34O4
1-[(3R,5R,8R,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
methyl (8E,11E,14E,17E)-5,6-dihydroxyicosa-8,11,14,17-tetraenoate C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17S)-17-[(1R)-1,2-dihydroxyethyl]-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one C21H34O4
(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid C21H34O4
1-[(3R,5S,8S,9S,10S,11S,13S,14S,17S)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H34O4
1-[(3S,5S,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone C21H34O4
(3R,5R,8S,9S,10S,13S,14S,17S)-17-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one C21H34O4
(3S,5R,8S,9S,10S,13S,14R,17R)-3,17-dihydroxy-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one C21H34O4
(Z)-7-[(1S,4R,5S,6R)-5-[(E,3S)-3-hydroxyoct-1-enyl]-2-oxabicyclo[2.2.1]heptan-6-yl]hept-5-enoic acid C21H34O4